Takeaways from AP's report on water quality and safety at US mobile home parks
The Associated Press examined an Environmental Protection Agency database on violations by water systems across the country, ranging from the tiniest up to major metropolitan areas. AP also surveyed states for their oversight of water systems.
Here's a look at key findings from the AP report:
Mobile home parks violate water rules more than cities and towns
Nearly 70% of mobile home parks that run their own water systems violated safe drinking water rules over the past five years. That's well above the rate for cities (48%) and larger towns (57%), according to EPA data.
The U.S. has some 50,000 water utilities, most serving small towns and rural areas. Many struggle to find expert staff and funding, and they violate clean water rules more often than the handful of large utilities that serve cities. But even among the hard-pressed small utilities, mobile home parks stand out.
The AP analysis found that more than half these parks failed to perform a required test for at least one contaminant or failed to properly report the results, in the past five years. And they are far more likely to be repeat offenders of safe drinking water rules overall.
Some mobile home parks go unmonitored
The problems may go beyond what the figures show. Some parks don't appear in EPA's database at all and may go completely unregulated.
For example, EPA officials were investigating high levels of cancer-causing arsenic in tap water at a Southern California mobile home park in 2021 when they realized there were several others in the area that weren't in their records, said Amy Miller, a former EPA head of enforcement in the region.
Some were found to have high levels of arsenic that residents had been drinking for years.
It's impossible to know how many under-the-radar parks there are. Most states aren't actively looking for them and say they don't find very many.
There's another way that problems with mobile home park water can escape attention. Some mobile home parks get their water from an outside source — a nearby town, for example. That water can be safe when it reaches the park boundary but become contaminated if the park has substandard or poorly installed piping. The EPA doesn't generally track water once it's on private property, so those problems can go unseen.
It may not be easy to escape bad water
Bad water isn't always unsafe. Residents of mobile home parks in Michigan, Iowa and elsewhere reported taps that frequently ran dry or problems with discolored water that looked like coffee or tea, stained their laundry and made them fearful to open their mouths in the shower, for example.
If residents are unhappy with management's response to such problems, it can be difficult to leave. That's because 'mobile' homes aren't all that mobile. Residents often own the home but rent the land they sit on, and it's difficult and expensive to move them.
Esther Sullivan, a professor of sociology at the University of Colorado, calls residents 'halfway homeowners' because of this dynamic. She said they often put up with problems because of the difficulty in moving.
Almost 17 million people in the U.S. live in mobile homes.
What some states are doing
Utah is the rare state that enforces safe drinking water standards even within parks that get their water from another provider, according to AP's survey of states.
And Colorado passed a law in 2023 that requires testing the water in every mobile home park. It gives health officials the ability to go beyond federal law to address taste, color and smell that can make people afraid to drink their water, even when it's not a health risk.
___
The Associated Press receives support from the Walton Family Foundation for coverage of water and environmental policy. The AP is solely responsible for all content. For all of AP's environmental coverage, visit https://apnews.com/hub/climate-and-environment
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Toronto Star
3 hours ago
- Toronto Star
Sarepta will resume gene therapy shipments after FDA review of recent patient death
WASHINGTON (AP) — Shares of beleaguered drugmaker Sarepta Therapeutics jumped in afterhours trading Monday after the company said it would resume shipping its gene therapy for some patients, following a brief pause requested by regulators. The Food and Drug Administration said it recommended lifting the hold for young patients with Duchenne's muscular dystrophy who are still able to walk. Regulators had requested the pause after the deaths of two older teenagers who were taking the therapy. The FDA also said in a statement it determined that a recently reported death of an 8-year-old boy was unrelated to the therapy.
Winnipeg Free Press
3 hours ago
- Winnipeg Free Press
Sarepta will resume gene therapy shipments after FDA review of recent patient death
WASHINGTON (AP) — Shares of beleaguered drugmaker Sarepta Therapeutics jumped in afterhours trading Monday after the company said it would resume shipping its gene therapy for some patients, following a brief pause requested by regulators. The Food and Drug Administration said it recommended lifting the hold for young patients with Duchenne's muscular dystrophy who are still able to walk. Regulators had requested the pause after the deaths of two older teenagers who were taking the therapy. The FDA also said in a statement it determined that a recently reported death of an 8-year-old boy was unrelated to the therapy. Company shares surged more than 16% after the announcement to $13.86 in afterhours trading. The jump is the latest in a series of drastic stock movements triggered by changing fortunes for the company's best-selling product. Elevidys is the first gene therapy approved in the U.S. for Duchenne's muscular dystrophy, the fatal muscle-wasting disease that affects boys and young men, resulting in early death. It received accelerated approval in 2023 for a narrow range of young patients and was expanded last year for use in older patients, including those who can no longer walk. The FDA decision Monday 'significantly improves Elevidys' sales outlook in the near-term,' Jefferies analyst Andrew Tsai told investors, in a note after the announcement. 'The street will feel relieved about the situation, suggesting meaningful stock upside potential.' Sarepta's therapy has been under scrutiny from regulators after two teenage boys died earlier this year from acute liver injury, a known side effect of the treatment. The FDA then requested a pause in shipments of the drug after the death of a third patient taking a different Sarepta therapy. FDA officials have suggested the company will need to provide new study data on safety to resume Elevidys' use in older patients. 'The FDA will continue to work with the sponsor regarding non-ambulatory patients, which remains subject to a voluntary hold, following two deaths,' FDA said in its statement. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Winnipeg Free Press
6 hours ago
- Winnipeg Free Press
Clemson's Dabo Swinney rooting for Hunter Renfrow as he attempts NFL comeback with Panthers
CHARLOTTE, N.C. (AP) — Hunter Renfrow remembers being cut by the Las Vegas Raiders on March 13, 2024, and not even caring all that much. He had no desire to play football. Physically, he felt awful. He'd lost 35 pounds, went a week with a 103-degree fever and was completely zapped of the energy and fire he was once known to bring to the football field. Running routes, catching passes and being blasted by defensive backs was the last thing on his mind. But after being diagnosed with a severe case of ulcerative colitis, a chronic inflammatory bowel disease that causes inflammation and ulcers in the lining of the large intestine and rectum, the 2021 Pro Bowler is now feeling like himself again. He's trying to make an NFL comeback with the Carolina Panthers, the team he rooted for as a kid growing up in Myrtle Beach, South Carolina. Dabo Swinney, his college coach at Clemson, believes if anyone can make it back it's Renfrow. 'You're playing football at the highest level and he just couldn't eat,' Swinney said. 'It affected him, and he was really done (with football). I didn't think he was gonna play again.' Neither did Renfrow. 'I was like, I'm never playing a football again,' Renfroe said. 'Like when you feel like that, you feel like you're letting your teammates down.' Renfrow's problems surfaced late in the 2021 season in which he caught a career-high 103 passes for 1,038 yards and nine touchdowns. He noticed his energy level had dropped off significantly and he could never seem to get it all the way back, even after taking a month off to prep for his first Pro Bowl appearance. The Raiders rewarded Renfrow with a two-year, $32 million contract extension that offseason, but he never came close to reaching that level of production again. He caught just 36 passes for 330 yards and two touchdowns in 2022 and 25 passes for 255 yards and no touchdowns in 2023, leading to his release. But after several hospital visits and a referral to a Charlotte-area pediatrician, Renfrow finally received a diagnosis. He began receiving treatment, started a new diet and saw his appetite return. By September he'd put back on the 35 pounds he'd lost and then some. His energy returned. He played pickleball, basketball and golf and the competitive juices began to return. As the 2024 NFL season went out without him, Renfrow privately began discussing a possible comeback with Swinney, who has remained a close friend and father figure. 'I was like Hunter, listen, you know you're gonna be 40 one day,' Swinney said. 'So if you got more left in you …' In January, Renfrow took Swinney's advice and began to work his way back into football shape. He asked his agent if the Panthers might be interested in giving him a workout. They were, and that ultimately led to a one-year, $1.22 million contract that included a modest $50,000 signing bonus. It was a no-lose proposition for the Panthers. But if Monday is any indication, Renfrow might just be a solid under-the-radar free agent addition for the Panthers. With Swinney observing from the Panthers sideline as a guest of coach Dave Canales, the 5-foot-10 Renfrow made two impressive catches reminiscent of the player who went from walk-on to catching the game-winning touchdown pass with 1 second remaining in Clemson's dramatic 35-31 win over Alabama in the national championship game in the 2016 season. Renfrow said he feels appreciative as he continues 'pushing toward something special.' While the unimposing Renfrow may look like an ordinary guy off the field, Swinney said that when he puts on the pads he 'turns into Superman.' 'He catches it. He makes plays,' Swinney said. 'He understands the leverage and influence and route-running and break points and how to set things up and how to play with his hands at full speed. And he's just got elite change of direction. … But he's a little guy that plays really big, and is really crafty. Just his ability to separate and change direction, that's hard to find.' Renfrow is no lock to make the Panthers roster. The Panthers have upgraded their wide receiver position in recent years, drafting Xavier Legette and Tetairoa McMillan in the first round in 2024 and 2025, respectively. They also have veteran wide receivers Adam Thielen and David Moore, and the team remains high on last year's surprise undrafted rookie standout Jalen Coker. But Canales likes what he's seen so far from Renfrow. 'He looks like the Hunter that I remember,' Canales said. Canales said Renfrow began to show a burst during the team's OTAs in the spring, and he's been pleased with his development ever since, citing the five-year NFL veteran's knowledge of coverages and leverages and ability to attack defenses. Thursdays Keep up to date on sports with Mike McIntyre's weekly newsletter. The next month will go a long way toward determining whether Renfrow is able to make it all the way back. Either way, at least he has his health. 'I'm just pulling for him,' Swinney said. 'He's having fun again. He's 29 and so I'm just happy that he's back out here. If he stays healthy he'll do what Renfrow does. That's just who he is.' ___ AP NFL:
